Sou Hu Cai Jing·2025-12-01 14:52Core Viewpoint - *ST Suwu has received a decision from the Shanghai Stock Exchange to terminate its stock listing due to significant violations, including false disclosures in annual reports and financial misstatements [1][5]. Group 1: Termination of Listing - On December 1, *ST Suwu announced it received a decision from the Shanghai Stock Exchange regarding the termination of its stock listing [1]. - The stock will enter a delisting preparation period starting December 9, with the last trading day expected to be December 29, lasting for 15 trading days [3][6]. - During the delisting preparation period, the stock will trade on a risk warning board [3]. Group 2: Violations and Penalties - The China Securities Regulatory Commission (CSRC) issued an administrative penalty decision on November 25, citing three major violations by *ST Suwu, including failure to disclose the actual controller and false financial reporting from 2018 to 2023 [5]. - The company was fined 10 million yuan, and its chairman and vice chairman were fined a total of 20.5 million yuan for their roles in the violations [5]. - The Shanghai Stock Exchange determined that these violations constituted a mandatory delisting condition under its listing rules [5]. Group 3: Company Profile and Market Data - *ST Suwu is a comprehensive listed company with a core focus on pharmaceuticals, significant involvement in real estate, and investment activities [6]. - As of November 25, the stock was trading at 1.24 yuan per share, with a total market capitalization of 880 million yuan [7]. - As of September 30, the number of shareholders was reported at 67,406, reflecting a decrease of 1,369 shareholders, or a 1.99% change [10][11].